Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells.
Immune escape
K-RAS
MHC class I
colorectal carcinoma
extracellular matrix protein
oncogene
proteoglycan
Journal
Oncoimmunology
ISSN: 2162-402X
Titre abrégé: Oncoimmunology
Pays: United States
ID NLM: 101570526
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
9
5
2022
pubmed:
10
5
2022
medline:
11
5
2022
Statut:
epublish
Résumé
The extracellular matrix component biglycan (BGN) plays an essential role in various physiological and pathophysiological processes. A deficient BGN expression associated with reduced immunogenicity was found in HER-2/neu-overexpressing cells. To determine whether BGN is suppressed by oncogene-driven regulatory networks, the expression and function of BGN was analyzed in murine and human BGN
Identifiants
pubmed: 35529675
doi: 10.1080/2162402X.2022.2069214
pii: 2069214
pmc: PMC9067524
doi:
Substances chimiques
Biglycan
0
Histocompatibility Antigens Class I
0
RNA, Messenger
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2069214Informations de copyright
© 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.
Déclaration de conflit d'intérêts
No potential conflict of interest was reported by the author(s)
Références
Int J Cancer. 2020 Dec 1;147(11):2996-3006
pubmed: 32415713
Curr Oncol Rep. 2021 Feb 13;23(3):28
pubmed: 33582927
FEBS J. 2010 Oct;277(19):3904-23
pubmed: 20840587
JCO Precis Oncol. 2017;2017:
pubmed: 29850653
Matrix Biol. 2015 Mar;42:11-55
pubmed: 25701227
Proteomics. 2007 Feb;7(3):385-98
pubmed: 17211828
Cell Rep. 2018 Apr 3;23(1):227-238.e3
pubmed: 29617662
Mol Cancer Res. 2013 Nov;11(11):1462-77
pubmed: 24025972
Cell Syst. 2018 Mar 28;6(3):271-281.e7
pubmed: 29596782
Br J Cancer. 2009 Feb 24;100(4):656-62
pubmed: 19190631
J Pathol. 1999 Mar;187(4):433-8
pubmed: 10398103
Curr Colorectal Cancer Rep. 2019 Apr;15(2):61-69
pubmed: 31130830
Biochemistry. 2015 Aug 4;54(30):4583-98
pubmed: 26177309
Cancer Cell. 2018 Apr 9;33(4):676-689.e3
pubmed: 29622463
J Biol Chem. 2004 Jun 4;279(23):24505-13
pubmed: 15044465
Biochim Biophys Acta. 2007 Aug;1773(8):1263-84
pubmed: 17126425
Cancer Res. 2008 Dec 15;68(24):10086-93
pubmed: 19074874
Front Immunol. 2021 May 13;12:679090
pubmed: 34054869
Semin Cancer Biol. 2020 May;62:48-67
pubmed: 31336150
N Engl J Med. 2020 Sep 24;383(13):1207-1217
pubmed: 32955176
Genomics. 1992 Jun;13(2):481-3
pubmed: 1612609
Cell Stem Cell. 2011 Nov 4;9(5):476-85
pubmed: 22056143
Nat Rev Drug Discov. 2020 Dec;19(12):902
pubmed: 33082552
Cell. 2018 Apr 5;173(2):305-320.e10
pubmed: 29625049
Cancer Res. 2004 Jan 1;64(1):215-20
pubmed: 14729627
Cancer Discov. 2018 Jun;8(6):730-749
pubmed: 29510987
Nat Rev Drug Discov. 2014 Nov;13(11):828-51
pubmed: 25323927
Cancer Res. 2000 Dec 1;60(23):6750-6
pubmed: 11118062
Proc Natl Acad Sci U S A. 1989 Apr;86(7):2403-7
pubmed: 2648401
Curr Cancer Drug Targets. 2019;19(3):210-221
pubmed: 29984655
Mod Pathol. 2013 Oct;26(10):1346-54
pubmed: 23599154
Clin Cancer Res. 2006 Mar 1;12(5):1647-53
pubmed: 16533793
Oncoimmunology. 2018 Jan 16;7(4):e1373233
pubmed: 29632715
Nat Biotechnol. 2020 Jun;38(6):675-678
pubmed: 32444850
Int J Cancer. 2012 Oct 15;131(8):1810-7
pubmed: 22290300
Cancer Discov. 2013 Oct;3(10):1108-12
pubmed: 24124232
Int J Mol Sci. 2021 Jul 14;22(14):
pubmed: 34299137
Int J Gen Med. 2021 Jul 15;14:3497-3509
pubmed: 34295178
Neoplasia. 2017 Aug;19(8):649-658
pubmed: 28732212
Cell. 1990 Jun 1;61(5):759-67
pubmed: 2188735
Semin Cancer Biol. 2019 Dec;59:23-35
pubmed: 31255772
Oncotarget. 2014 Apr 15;5(7):1885-96
pubmed: 24681892
FEBS J. 2021 Dec;288(23):6683-6699
pubmed: 34227245
Nat Commun. 2020 Oct 28;11(1):5439
pubmed: 33116132
Mod Pathol. 2007 Mar;20(3):375-83
pubmed: 17277760
J Hematol Oncol. 2021 Jul 23;14(1):116
pubmed: 34301278
PLoS One. 2013 Nov 06;8(11):e80084
pubmed: 24223213
J Immunother Cancer. 2018 Nov 19;6(1):123
pubmed: 30454021
Clin Transl Med. 2021 Mar;11(3):e306
pubmed: 33783999
J Immunol Res. 2014;2014:686879
pubmed: 24741617
Cell. 1988 May 20;53(4):549-54
pubmed: 2453289
Semin Cancer Biol. 2020 May;62:31-47
pubmed: 31412297
Cell Mol Immunol. 2021 Mar;18(3):556-565
pubmed: 33473191
FEBS J. 2017 Jan;284(1):10-26
pubmed: 27860287
J Chem Phys. 2015 Feb 14;142(6):064112
pubmed: 25681892
Cell. 2018 Apr 5;173(2):400-416.e11
pubmed: 29625055
Nature. 2020 Mar;579(7800):567-574
pubmed: 32214244
FASEB J. 2021 Apr;35(4):e21461
pubmed: 33724568
Nat Methods. 2008 Jul;5(7):621-8
pubmed: 18516045
J Biol Chem. 2002 Sep 27;277(39):36118-28
pubmed: 12140283
Int J Clin Exp Pathol. 2013 Oct 15;6(11):2497-505
pubmed: 24228112
Breast Cancer Res. 2021 May 10;23(1):51
pubmed: 33966638
Signal Transduct Target Ther. 2021 Apr 9;6(1):144
pubmed: 33833221
Mod Pathol. 2011 Dec;24(12):1571-7
pubmed: 21743433
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
Int J Colorectal Dis. 2019 Aug;34(8):1491-1496
pubmed: 31309326
Arch Gynecol Obstet. 2014 Mar;289(3):649-55
pubmed: 24013431
J Biol Chem. 2010 Oct 1;285(40):30419-26
pubmed: 20663889
Methods Mol Biol. 2005;294:23-9
pubmed: 15576902
Nat Rev Drug Discov. 2020 Aug;19(8):533-552
pubmed: 32528145
Matrix Biol. 2016 Jan;49:10-24
pubmed: 26163349
Cell. 2018 Apr 5;173(2):291-304.e6
pubmed: 29625048
Mol Membr Biol. 2008 Jan;25(1):72-82
pubmed: 18097955
J Clin Invest. 2005 Aug;115(8):2223-33
pubmed: 16025156
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Mol Cell Biochem. 2021 Nov;476(11):3935-3950
pubmed: 34181183
J Biol Chem. 2012 Jul 13;287(29):24320-9
pubmed: 22582394
Nat Commun. 2019 Dec 12;10(1):5679
pubmed: 31831737
Nature. 2014 Sep 18;513(7518):382-7
pubmed: 25043054
Br J Cancer. 2010 Feb 16;102(4):693-703
pubmed: 20147967
Cell. 2019 May 2;177(4):1035-1049.e19
pubmed: 31031003
Int J Cancer. 2010 Nov 1;127(9):2076-87
pubmed: 20473902
Int J Cancer. 2009 Oct 1;125(7):1626-39
pubmed: 19569244
Immunity. 2017 Dec 19;47(6):1083-1099.e6
pubmed: 29246442
Cell. 2018 Apr 5;173(2):321-337.e10
pubmed: 29625050
FEBS J. 2019 Aug;286(15):2965-2979
pubmed: 30776184
Br J Cancer. 2019 Apr;120(8):815-818
pubmed: 30862951
Nat Genet. 2019 Feb;51(2):308-318
pubmed: 30643250
Prostate. 1985;7(2):161-9
pubmed: 2413431
Semin Cancer Biol. 2019 Feb;54:1-13
pubmed: 29524560
Methods Mol Biol. 2019;1952:1-20
pubmed: 30825161